ARCHIVES

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Recompetition of Drug Discovery Groups

October 22, 1993

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995

Commerce Dept. Socks NCI For Cancergram Paid Subscriptions; NCAB Committee Oks OD Requests

October 22, 1982

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

“Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program

March 31, 1978

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996